Search research articles
Contact Us
Filters
Showing results (31-40 of 515) with videos related to
Page
of 52
Sort By:
Diabetes
|
July 2, 1999
New concept for long-acting insulin: spontaneous conversion of an inactive modified insulin to the active hormone in circulation: 9-fluorenylmethoxycarbonyl derivative of insulin
E Gershonov, Y Shechter, M Fridkin
Immunobiology
|
December 29, 2000
A peptide based on the CDR1 of a pathogenic anti-DNA antibody is more efficient than its analogs in inhibiting autoreactive T cells
E Eilat, M Fridkin, E Mozes
International Journal of Peptide and Protein Research
|
September 1, 1986
Peptides related to the calcium binding domains II and III of calmodulin. Synthesis and calmodulin-like features
R Buchta, E Bondi, M Fridkin
Journal of the National Cancer Institute
|
July 1, 1983
Inhibition by tuftsin of Rauscher virus leukemia development in mice
A Knyszynski, P Gottlieb, M Fridkin
Journal of Medicinal Chemistry
|
September 6, 2002
N-[(2-Sulfo)-9-fluorenylmethoxycarbonyl](3)-gentamicin C(1) is a long-acting prodrug derivative
Yoram Shechter, Haim Tsubery, Mati Fridkin
Biochemical and Biophysical Research Communications
|
May 15, 2003
[2-Sulfo-9-fluorenylmethoxycarbonyl]3-exendin-4-a long-acting glucose-lowering prodrug
Yoram Shechter, Haim Tsubery, Mati Fridkin
Clinics in Chest Medicine
|
July 1, 1999
Antimicrobial resistance in intensive care units
S K Fridkin, R P Gaynes
Clinical Microbiology Reviews
|
October 1, 1996
Epidemiology of nosocomial fungal infections
S K Fridkin, W R Jarvis
Molecular and Cellular Biochemistry
|
May 7, 1980
The phagocytosis stimulating peptide tuftsin: further look into structure-function relationships
Y Stabinsky, P Gottlieb, M Fridkin
Biochimica Et Biophysica Acta
|
December 22, 1976
Structure-activity relationships of luliberin substituted at position 8
M Shinitzky, E Hazum, M Fridkin
Page
of 52
Search research articles
Search
Showing results (31-40 of 515) with videos related to
Sort By:
Page
of 52
Diabetes
|
July 2, 1999
New concept for long-acting insulin: spontaneous conversion of an inactive modified insulin to the active hormone in circulation: 9-fluorenylmethoxycarbonyl derivative of insulin
E Gershonov, Y Shechter, M Fridkin
Immunobiology
|
December 29, 2000
A peptide based on the CDR1 of a pathogenic anti-DNA antibody is more efficient than its analogs in inhibiting autoreactive T cells
E Eilat, M Fridkin, E Mozes
International Journal of Peptide and Protein Research
|
September 1, 1986
Peptides related to the calcium binding domains II and III of calmodulin. Synthesis and calmodulin-like features
R Buchta, E Bondi, M Fridkin
Journal of the National Cancer Institute
|
July 1, 1983
Inhibition by tuftsin of Rauscher virus leukemia development in mice
A Knyszynski, P Gottlieb, M Fridkin
Journal of Medicinal Chemistry
|
September 6, 2002
N-[(2-Sulfo)-9-fluorenylmethoxycarbonyl](3)-gentamicin C(1) is a long-acting prodrug derivative
Yoram Shechter, Haim Tsubery, Mati Fridkin
Biochemical and Biophysical Research Communications
|
May 15, 2003
[2-Sulfo-9-fluorenylmethoxycarbonyl]3-exendin-4-a long-acting glucose-lowering prodrug
Yoram Shechter, Haim Tsubery, Mati Fridkin
Clinics in Chest Medicine
|
July 1, 1999
Antimicrobial resistance in intensive care units
S K Fridkin, R P Gaynes
Clinical Microbiology Reviews
|
October 1, 1996
Epidemiology of nosocomial fungal infections
S K Fridkin, W R Jarvis
Molecular and Cellular Biochemistry
|
May 7, 1980
The phagocytosis stimulating peptide tuftsin: further look into structure-function relationships
Y Stabinsky, P Gottlieb, M Fridkin
Biochimica Et Biophysica Acta
|
December 22, 1976
Structure-activity relationships of luliberin substituted at position 8
M Shinitzky, E Hazum, M Fridkin
Page
of 52